{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:11:18Z","timestamp":1768353078984,"version":"3.49.0"},"reference-count":38,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Diabetic patients are known to have reduced long-term survival following percutaneous transluminal coronary angioplasty compared with nondiabetic patients. However, it is unknown whether this survival disadvantage has persisted in the era of contemporary percutaneous coronary intervention (PCI) techniques, which include the widespread use of stents and the availability of platelet glycoprotein (GP) IIb\/IIIa inhibitors.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Three hospitals in New York City contributed prospectively defined data on 4,284 patients undergoing PCI. The primary end point was all-cause mortality following hospital discharge for PCI.<\/jats:p>\n               <jats:p>RESULTS\u2014Hypertension, renal insufficiency, and renal failure requiring dialysis were all more common in diabetic patients, whereas active smoking was less frequent. Congestive heart failure on admission was more common in diabetic than nondiabetic patients (7.7 vs. 4.0%, P &amp;lt; 0.001). Stents were placed in 78% of nondiabetic patients and 75% of diabetic patients (P = 0.045). Platelet GP IIb\/IIIa antagonists were administered to 23% of nondiabetic and 24% of diabetic patients (P = NS). At a mean follow-up of 3 years, mortality was 8% among nondiabetic patients and 13% for diabetic patients (P &amp;lt; 0.001). After adjustment for differences in baseline characteristics between nondiabetic and diabetic patients, diabetes remained a significant independent hazard for late mortality (hazard ratio 1.462, 95% CI 1.169\u20131.828; P = 0.001).<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Following contemporary PCI, diabetic patients continue to have worse survival than nondiabetic patients.<\/jats:p>","DOI":"10.2337\/diacare.27.5.1137","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"1137-1142","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":40,"title":["Effect of Diabetes on Long-Term Mortality Following Contemporary Percutaneous Coronary Intervention"],"prefix":"10.2337","volume":"27","author":[{"given":"Sean R.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Medicine (Cardiology), Beth Israel Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak A.","family":"Vakili","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Beth Israel Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Beth Israel Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Sanborn","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Beth Israel Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine (Cardiology), Beth Israel Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031219152152400_R1","doi-asserted-by":"crossref","unstructured":"Kannel WB, McGee DL: Diabetes and cardiovascular risk: the Framingham Study. JAMA\u2008241:2035\u20132038, 1979","DOI":"10.1001\/jama.241.19.2035"},{"key":"2022031219152152400_R2","doi-asserted-by":"crossref","unstructured":"Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care\u200816:434\u2013444, 1993","DOI":"10.2337\/diacare.16.2.434"},{"key":"2022031219152152400_R3","doi-asserted-by":"crossref","unstructured":"Kannel W: Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J\u2008110:1100\u20131107, 1985","DOI":"10.1016\/0002-8703(85)90224-8"},{"key":"2022031219152152400_R4","doi-asserted-by":"crossref","unstructured":"Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ, GUSTO-1 Investigators: Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol\u200830:171\u2013179, 1997","DOI":"10.1016\/S0735-1097(97)00118-6"},{"key":"2022031219152152400_R5","doi-asserted-by":"crossref","unstructured":"Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A: Impact of diabetes on long-term prognosis in patients with unstable angina and non Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation\u2008102:1014\u20131019, 2000","DOI":"10.1161\/01.CIR.102.9.1014"},{"key":"2022031219152152400_R6","doi-asserted-by":"crossref","unstructured":"BARI Investigators: Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation\u200896:1761\u20131769, 1997","DOI":"10.1161\/01.CIR.96.6.1761"},{"key":"2022031219152152400_R7","doi-asserted-by":"crossref","unstructured":"Kurbaan AS, Bowker TJ, Ilsley CD, Sigwart U, Rickards AF, CABRI Investigators (Coronary Angioplasty versus Bypass Revascularization Investigation): Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol\u200887:947\u2013950, 2001","DOI":"10.1016\/S0002-9149(01)01426-6"},{"key":"2022031219152152400_R8","doi-asserted-by":"crossref","unstructured":"Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB 3rd: Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation\u200891:979\u2013989, 1995","DOI":"10.1161\/01.CIR.91.4.979"},{"key":"2022031219152152400_R9","doi-asserted-by":"crossref","unstructured":"Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation\u200896:2551\u20132556, 1997","DOI":"10.1161\/01.CIR.96.8.2551"},{"key":"2022031219152152400_R10","doi-asserted-by":"crossref","unstructured":"Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW: Coronary angioplasty in diabetic patients: the National, Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation\u200894:1818\u20131825, 1996","DOI":"10.1161\/01.CIR.94.8.1818"},{"key":"2022031219152152400_R11","doi-asserted-by":"crossref","unstructured":"Narins CR, Holmes DR Jr, Topol EJ: A call for provisional stenting: the balloon is back. Circulation\u200897:1298\u20131305, 1998","DOI":"10.1161\/01.CIR.97.13.1298"},{"key":"2022031219152152400_R12","doi-asserted-by":"crossref","unstructured":"Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Columbo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, Stent Restenosis Study Investigators: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med\u2008331:496\u2013501, 1994","DOI":"10.1056\/NEJM199408253310802"},{"key":"2022031219152152400_R13","doi-asserted-by":"crossref","unstructured":"Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Columbo A, Goy JJ, van den Heuvel P, Delcan J, Morel M, Benestent Study Group: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med\u2008331:489\u2013495, 1994","DOI":"10.1056\/NEJM199408253310801"},{"key":"2022031219152152400_R14","doi-asserted-by":"crossref","unstructured":"EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med\u2008330:956\u2013961, 1994","DOI":"10.1056\/NEJM199404073301402"},{"key":"2022031219152152400_R15","doi-asserted-by":"crossref","unstructured":"EPILOG Investigators: Platelet glycoprotein IIb\/IIIa receptor blockage and low-dose heparin during percutaneous coronary revascularization. N Engl J Med\u2008336:1689\u20131696, 1997","DOI":"10.1056\/NEJM199706123362401"},{"key":"2022031219152152400_R16","doi-asserted-by":"crossref","unstructured":"CAPTURE Investigators: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet\u2008349:1429\u20131435, 1997","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"2022031219152152400_R17","doi-asserted-by":"crossref","unstructured":"EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Lancet\u2008352:87\u201392, 1998","DOI":"10.1016\/S0140-6736(98)06113-3"},{"key":"2022031219152152400_R18","doi-asserted-by":"crossref","unstructured":"IMPACT-II Investigators: Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet\u2008349:1422\u20131428, 1997","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"2022031219152152400_R19","doi-asserted-by":"crossref","unstructured":"ESPRIT Investigators: Novel dosing regimen in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial. Lancet\u2008356:2037\u20132044, 2000","DOI":"10.1016\/S0140-6736(00)03400-0"},{"key":"2022031219152152400_R20","doi-asserted-by":"crossref","unstructured":"Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ: Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol\u200835:922\u2013928, 2000","DOI":"10.1016\/S0735-1097(99)00650-6"},{"key":"2022031219152152400_R21","doi-asserted-by":"crossref","unstructured":"Boyle CA, Decoufle P: National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol\u2008131:160\u2013168, 1990","DOI":"10.1093\/oxfordjournals.aje.a115470"},{"key":"2022031219152152400_R22","doi-asserted-by":"crossref","unstructured":"Newman TB, Brown AN: Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc\u20084:233\u2013237, 1997","DOI":"10.1136\/jamia.1997.0040233"},{"key":"2022031219152152400_R23","doi-asserted-by":"crossref","unstructured":"King H, Aubert RE, Herman WH: Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections. Diabetes Care\u200821:1414\u20131431, 1998","DOI":"10.2337\/diacare.21.9.1414"},{"key":"2022031219152152400_R24","doi-asserted-by":"crossref","unstructured":"Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, et al: Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol\u200853:77C\u201381C, 1984","DOI":"10.1016\/0002-9149(84)90752-5"},{"key":"2022031219152152400_R25","doi-asserted-by":"crossref","unstructured":"Myler RK, Topol EJ, Shaw RE, Stertzer SH, Clark DA, Fishman J, Murphy MC: Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn\u200813:1\u201315, 1987","DOI":"10.1002\/ccd.1810130102"},{"key":"2022031219152152400_R26","doi-asserted-by":"crossref","unstructured":"Vandormael MG, Deligonul U, Kern MJ, Harper M, Presant S, Gibson P, Galan K, Chaitman BR: Multilesion coronary angioplasty: clinical and angiographic follow-up. J Am Coll Cardiol\u200810:246\u2013252, 1987","DOI":"10.1016\/S0735-1097(87)80003-7"},{"key":"2022031219152152400_R27","doi-asserted-by":"crossref","unstructured":"Hollman J, Badhwa K, Beck GJ, Granco I, Simpfendorfer C: Risk factors for recurrent stenosis following successful coronary angioplasty. Cleve Clin J Med\u200856:517\u2013523, 1989","DOI":"10.3949\/ccjm.56.5.517"},{"key":"2022031219152152400_R28","doi-asserted-by":"crossref","unstructured":"Quigley PJ, Hlatky MA, Hinohara T, Rendall DS, Perez JA, Phillips HR, Califf RM, Stack RS: Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent stenosis. Am J Cardiol\u200863:409\u2013413, 1989","DOI":"10.1016\/0002-9149(89)90309-3"},{"key":"2022031219152152400_R29","doi-asserted-by":"crossref","unstructured":"Deligonul U, Vandormeal M, Kern MJ, Galan KL: Repeat coronary angioplasty and predictors of recurrent stenosis. Am J Cardiol\u2008117:997\u20131002, 1989","DOI":"10.1016\/0002-8703(89)90852-1"},{"key":"2022031219152152400_R30","doi-asserted-by":"crossref","unstructured":"Weintraub WS, Kosinski AS, Brown CL, King SB III: Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol\u200821:6\u201314, 1993","DOI":"10.1016\/0735-1097(93)90711-9"},{"key":"2022031219152152400_R31","doi-asserted-by":"crossref","unstructured":"Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K, Richard F, Lablanche JM, McFadden EP, Bertrand ME: Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation\u2008103:1218\u20131224, 2001","DOI":"10.1161\/01.CIR.103.9.1218"},{"key":"2022031219152152400_R32","doi-asserted-by":"crossref","unstructured":"Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME: Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation\u200896:1454\u20131460, 1997","DOI":"10.1161\/01.CIR.96.5.1454"},{"key":"2022031219152152400_R33","doi-asserted-by":"crossref","unstructured":"Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol\u200832:584\u2013589, 1998","DOI":"10.1016\/S0735-1097(98)00286-1"},{"key":"2022031219152152400_R34","doi-asserted-by":"crossref","unstructured":"Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A: Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol\u200832:1866\u20131873, 1998","DOI":"10.1016\/S0735-1097(98)00467-7"},{"key":"2022031219152152400_R35","doi-asserted-by":"crossref","unstructured":"Knobler H, Savion N, Shenkman B, Kotev-Emeth S, Varon D: Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res\u200890:181\u2013190, 1998","DOI":"10.1016\/S0049-3848(98)00050-4"},{"key":"2022031219152152400_R36","doi-asserted-by":"crossref","unstructured":"Tschoepe D, Roesen P, Kaufmann L, Schauseil S, Kehrel B, Ostermann H, Gries FA: Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest\u200820:166\u2013170, 1990","DOI":"10.1111\/j.1365-2362.1990.tb02264.x"},{"key":"2022031219152152400_R37","doi-asserted-by":"crossref","unstructured":"Velianou JL, Mathew V, Wilson SH, Barsness GW, Grill DE, Holmes DR Jr: Effect of abciximab on late adverse events in patients with diabetes undergoing stent implantation. Am J Cardiol\u200886:1063\u20131068, 2000","DOI":"10.1016\/S0002-9149(00)01160-7"},{"key":"2022031219152152400_R38","doi-asserted-by":"crossref","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation\u2008100:1134\u20131146, 1999","DOI":"10.1161\/01.CIR.100.10.1134"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/27\/5\/1137\/565665\/zdc00504001137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/27\/5\/1137\/565665\/zdc00504001137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T20:40:20Z","timestamp":1647117620000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/27\/5\/1137\/27472\/Effect-of-Diabetes-on-Long-Term-Mortality"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.27.5.1137","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}